Northwestern University
  Search  
Northwestern
University Relations
UNIVERSITY RELATIONS
Media Relations
University Relations > Media Relations > Northwestern News > Press Release
  About Media Relations  
    Who we are and what we do  
  News Headlines  
    Current headlines from Media Relations and Northwestern media coverage  
  Press Release Archive  
    Complete catalogue of Press Releases  
  Newsfeed/Audio  
    Faculty commentary and guest speakers  
  Observer Online  
    Northwestern's faculty and staff newspaper  
  Media Guide to Experts  
    Find faculty experts on a variety of subjects  
  Northwestern Fact Sheet  
    Northwestern facts and history  
  Media Contact Information  
    E-mail addresses and phone numbers  
Northwestern News
  [text only]  Last updated 04/08/2005
   

MEDIA CONTACT: Elizabeth Crown at (312) 503-8928 or at e-crown@northwestern.edu

February 3, 2004

Soybean Chemical May Treat Prostate Cancer

CHICAGO --- Genistein is a chemical found in soybeans that blocks development of prostate cancer in laboratory models of the disease. Now, a Northwestern University study will determine whether genistein is effective in the treatment of prostate cancer in humans.

The principal investigator for the study at Northwestern is Raymond Bergan, M.D., assistant professor of medicine, division of hematology/oncology, at the Feinberg School of Medicine. Bergan is also director of experimental therapeutics at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

To qualify for the study, men must recently have been diagnosed with prostate cancer and plan to have surgery to have their prostate removed. Participation in the study will not delay surgery.

Participants will take one pill a day, either before or after surgery. The effects of the study treatment on prostate cancer will be assessed in the laboratory.

For more information, call 312-908-5284.